XML 61 R54.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 1 month 6 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,517,897
Number of grants, issued | shares 829,404
Number of grants, exercised | shares (22,039)
Number of grants, cancelled/forfeited | shares (101,812)
Number of units, grant outstanding ending balance | shares 5,223,450
Number of grants, vested | shares 2,800,191
Number of grants, unvested | shares 2,423,259
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 14.38
Weighted average exercise price, grants exercised | $ / shares 13.73
Weighted average exercise price, grants issued | $ / shares 15.32
Weighted average exercise price, cancelled/forfeited | $ / shares 14.51
Weighted average exercise price, grant outstanding ending balance | $ / shares 14.53
Weighted average exercise price, grants vested | $ / shares 13.74
Weighted average exercise price, grants unvested | $ / shares $ 15.44
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years
Weighted Average Remaining Contractual Term, Grants Vested 6 years 1 month 6 days
Aggregate Intrinsic Value, grants outstanding | $ $ 7.3
Aggregate Intrinsic Value, grants vested | $ $ 5.0
First Advantage Corporation [Member] | 2020 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,602,966
Number of grants, exercised | shares (287,814)
Number of grants, cancelled/forfeited | shares (29,074)
Number of units, grant outstanding ending balance | shares 1,286,078
Number of grants, vested | shares 880,695
Number of grants, unvested | shares 405,383
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants exercised | $ / shares 5.11
Weighted average exercise price, cancelled/forfeited | $ / shares 5.19
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.13
Weighted average exercise price, grants unvested | $ / shares $ 5.2
Weighted Average Remaining Contractual Term, Grants Outstanding 4 years 4 months 24 days
Weighted Average Remaining Contractual Term, Grants Vested 4 years 4 months 24 days
Aggregate Intrinsic Value, grants outstanding | $ $ 13.2
Aggregate Intrinsic Value, grants vested | $ $ 9.0